OBJECTIVES To compare rates of eye care visits and vision impairment among working-age adults with vision insurance vs without, among the total sample of Behavioral Risk Factor Surveillance Survey respondents and among a subsample of respondents who had diagnoses of glaucoma, age-related macular degeneration (ARMD), and/or cataract. DESIGN Using the Behavioral Risk Factor Surveillance Survey ...

PURPOSE To evaluate the comparability of articles in the peer-reviewed literature assessing the (1) patient value and (2) cost-utility (cost-effectiveness) associated with interventions for neovascular age-related macular degeneration (ARMD). METHODS A search was performed in the National Library of Medicine database of 16 million peer-reviewed articles using the key words cost-utility, cost-...

The exudative form of Age-Related Macular Degeneration (ARMD) is associated with a particularly poor visual prognosis and accounts for 88% of ARMD sufferers who are registered blind.' In this disease, characteristic changes occur in the posterior pole of the eye within the confines of the macula which is the region of the retina responsible for central vision. When visual loss results from prog...

PURPOSE The aim of this study is to determine the effectiveness, safety and cost of aflibercept in the treatment of wet age-related macular degeneration (ARMD) refractory to ranibizumab. METHODS Retrospective observational study was conducted on patients diagnosed with wet ARMD, and previously treated with ranibizumab. Efficacy variables assessed were changes in visual acuity (BCVA) and anato...

Age-related macular degeneration (ARMD) is the leading cause of vision loss in developed countries. Hallmarks of the disease are well known; indeed, this pathology is characterized by lipofuscin accumulation, is principally composed of lipid-containing residues of lysosomal digestion. The N-retinyl-N-retinylidene ethanolamine (A2E) retinoid which is thought to be a cytotoxic component for RPE i...

INTRODUCTION Age-related macular degeneration is a serious visual disorder of the central retina and was recently reported to be associated with genetic background. Here we describe a genetic link to early onset age-related macular degeneration in members of an Asian family. CASE PRESENTATION A 73-year-old Asian woman developed age-related macular degeneration in the fifth decade of her life ...

Age-related macular degeneration (ARMD) is the most common cause of permanent visual loss in the elderly. Advancing age, as the name suggests, is a major risk factor. Vascular endothelial growth factor. (VEGF) along with other factors could be responsible for the dramatic damage in the eyes. Although uncommon in pre-senile group, this disorder can also occur unrelated to age, such as pathologic...

PURPOSES To assess the risk factors of age-related macular degeneration in Argentina using a case-control study. METHODS Surveys were used for subjects' antioxidant intake, age/gender, race, body mass index, hypertension, diabetes (and type of treatment), smoking, sunlight exposure, red meat consumption, fish consumption, presence of age-related macular degeneration and family history of age-...

OBJECTIVE To analyse satisfaction and patient preferences on the location where they receive an intravitreal injection. METHOD A survey was conducted with the intention of analysing these patients who attended the macula clinic and have been intervened using an intravitreal injection at least once in the day hospital or in the theatre setting, comparing both locations. RESULTS The majority ...

Macular pigment optical density (MPOD)-assessed using customized heterochromatic flicker photometry (cHFP)-is related to better cognition and brain lutein among adults. However, the reliability of MPOD assessed by cHFP has not been investigated in children. We assessed inter-session reliability of MPOD using modified cHFP. 7-10-year-olds (n = 66) underwent cHFP over 2 visits using 11 examiners....